Biophilia Tracker X3 Understanding and Preventing Cancer

Understand the direction of the human body and prevent cancer with the Biophilia Tracker X3

Cancer single blood test

Scientists say a single blood test to detect cancer earlier is a step closer after they identified more than 800 possible signs of cancer, known as biomarkers, in the blood of cancer patients.

Study author Professor Ian Cree, from the University of Warwick and Coventry University Hospital, said in a statement: "This is a new approach to early detection and the first of its kind to systematically review a single blood-based screening. The test will be a game-changer for early detection of cancer, which could help make it a curable disease for more patients.

All cancers leave marks in the blood, raising the possibility of general screening tests for many different types of cancer.

"We believe we have identified all relevant biomarkers; the next step is to identify the best biomarkers for cancer detection."

Finding ways to detect cancer earlier could help provide more treatment options earlier and save more lives.

The research could open the way for new, less invasive screening tests that can detect more cancers at an earlier stage, possibly including some rare types that are more likely to be treated.

The UK Consortium for Early Cancer Detection carried out the research, which involved screening more than 19,000 scientific papers. The group was funded by Cancer Research UK.

The identified biomarkers will be reviewed and grouped before further development in laboratory studies.

The findings were presented this week at the National Cancer Institute Cancer Conference in Liverpool, UK.

Sara Hiom, director of early diagnosis at Cancer Research UK, said in a statement: "This is an innovative and promising new approach. Although at an early stage, it shows that what we know about cancer 'markers' and new technologies is How it increases. Combined to provide new opportunities to detect cancer faster."

Diagnosing cancer early often means more effective treatment, which means better survival rates. Our goal for the next 20 years is that three out of four cancer patients will live at least 10 years after diagnosis. "

You can also opt for the Biophilia Tracker X3. It can help you understand trends in various human diseases and is a more advanced approach to tackle cancer faster.